Table 7. Economic comparison with other studies (base = 6 months periods).
| Kahan (base 1998–2000) | Mazières (base 2003) | |||
|---|---|---|---|---|
| Control | Synvisc | Suplasn | ||
| Post M1-M6 | Post M1-M6 | Pre treatment | Post M1-M6 | |
| 6 months | 6 months | 6 months | 6 months | |
| Physician visits (all) | € 68 | € 91 | € 86 | € 42 |
| Other health professionals | € 110 | € 41 | ||
| Examinations (imaging) | € 21 | € 21 | € 50 | € 11 |
| Drug treatments (w/o IA HA) | € 181 | € 109 | € 141 | € 113 |
| Medical devices (IA HA) | € 0 | € 58 | € 0 | € 48 |
| Hospitalization—Rehabilitation | € 255 | € 231 | € 31 | € 48 |
| Non-medical costs | € 34 | € 29 | € 201 | € 177 |
| Total cost, per patient | € 560 | € 540 | € 618 | € 480 |
Expenses have been re-calculated prorata temporis on 6-months periods, to allow comparison with our study.
Higher costs are seen on several items (in italic characters), but the differences between groups were relevant.
- Hospitalization-rehabilitation, covering all pathologies in Kahan study.
- Other health professionals: nurses (at home) and therapists, in Mazières study.
- Non-medical costs: mostly sick leaves, covering all pathologies in Mazières study.